Corbus Pharmaceuticals
CRBP
CRBP
107 hedge funds and large institutions have $243M invested in Corbus Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 41 increasing their positions, 19 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.9% less ownership
Funds ownership: 100.59% → 97.69% (-2.9%)
50% less capital invested
Capital invested by funds: $486M → $243M (-$243M)
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Holders
107
Holding in Top 10
2
Calls
$22.9M
Puts
$18.9M
Top Buyers
| 1 | +$18.8M | |
| 2 | +$12.9M | |
| 3 | +$12.4M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$7.22M |
| 5 |
ACM
Altium Capital Management
New York
|
+$4.02M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$14.3M | |
| 3 | -$11.3M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$10.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.8M |